Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
暂无分享，去创建一个
Shengfang Jin | P. Iversen | M. Rolfe | J. Sampath | W. Chin | A. Dantzig | R. Shepard | V. Krishnan | William L Perry | Mark Williamson | A. Shyjan | K. A. O'Brien | V. Peek | Robert E. B. Moore | B. Yaden | A. Lesoon | Michelle Tighe